Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019693 (
HIV
)
170,526
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The interaction of partially double stranded DNA oligonucleotides with
HIV
-1 RT was studied by investigating their ability to inhibit the homopolymeric poly(rC) directed (dG) synthesis reaction. A 20/18mer oligonucleotide, with a sequence based on the Lys3-
tRNA
primer region, showed stronger inhibition of the homopolymeric RT reaction than a G/C rich oligonucleotide series lacking or possessing a hairpin moiety. Interaction of the enzyme with the G/C rich oligonucleotides, as determined by IC50 measurements, was insensitive to the extent of the unpaired template region at the 3' or 5' position. Addition of a hairpin moiety, composed of four thymidine bases, onto G/C rich oligonucleotides increase their inhibitory potency (at least six times) and shifted the mode of inhibition of RT to competitive with respect to poly (rC).(dG), which was otherwise mixed (competitive/noncompetitive) for the linear G/C rich and 20/18mer oligonucleotides. The results indicate that interaction of the enzyme with the primer/template stem, but not with the unpaired template region, is an important step in complex formation.
...
PMID:Inhibition of HIV-1 reverse transcriptase by defined template/primer DNA oligonucleotides: effect of template length and binding characteristics. 753 76
Retroviral nucleocapsid (NC) protein is an integral part of the virion nucleocapsid where it is in tight association with genomic RNA and the
tRNA
primer. NC protein is necessary for the dimerization and encapsidation of genomic RNA, the annealing of the
tRNA
primer to the primer binding site (PBS) and the initial strand transfer event. Due to the general nature of NC protein-promoted annealing, its use to improve nucleic acid interactions in various reactions can be envisioned. Parameters affecting NC-promoted nucleic acid annealing of NCp7 from
HIV
-1 have been analyzed. The promotion of RNA:RNA and RNA:DNA annealing by NCp7 is more sensitive to the concentration of MgCl2 than the promotion of DNA:DNA hybridization. Stimulation of complex formation for all three complexes was efficient at 0-90 mM NaCl, between 23 and 55 degrees C and at pH values between 6.5 and 9.5, inclusive. Parameters affecting NCp7-promoted hybridization of
tRNA
(Lys,3) to the PBS, which appears to be specific for NC protein, will be discussed. Results implicate the basic regions of NCp7, but not the zinc fingers, in promoting the annealing of complementary nucleic acid sequences. Finally, NCp7 strand transfer activity aids the formation of the most stable nucleic acid complex.
...
PMID:Analysis of the nucleic acid annealing activities of nucleocapsid protein from HIV-1. 754 98
The stimulatory effect of Mg2+ and Mn2+ on the ribonuclease H (RNase H) functions of
HIV
-1 reverse transcriptase (RT) has been evaluated using a model 90-nt RNA template/36-nt DNA primer. Wild type enzyme exhibits similar endonuclease and directional processing activities in response to both cations, while RNase H activity (hydrolysis of double-stranded RNA) is only evident in the presence of Mn2+. Enzyme altered at the p66 residue Glu478 (Glu478-->Gln478), which participates in metal ion binding, is completely inactive in Mg2+. However, Mn2+ restores specifically its endoribonuclease activity. In the presence of Mn2+, mutant RT also catalyzes specific removal of the
tRNA
replication primer, eliminating the possibility of contaminating Escherichia coli RNase H in our recombinant enzyme. However, the efficiency with which mutant RT catalyzes transfer of nascent DNA between RNA templates (an event mandating RNase H activity) is severely reduced. These findings raise the possibility that directional processing activity is required to accelerate transfer of nascent DNA between templates during retroviral replication.
...
PMID:Divalent cation modulation of the ribonuclease functions of human immunodeficiency virus reverse transcriptase. 754 83
HIV
-1 Rev protein directs nuclear export of pre-mRNAs and mRNAs containing its binding site, the Rev response element (RRE). To define how Rev acts, we used conjugates between bovine serum albumin (BSA) and peptides comprising the Rev activation domain (BSA-R). BSA-R inhibited Rev-mediated nuclear RNA export, whereas a mutant activation domain peptide conjugate did not. BSA-R did not affect the export of mRNA,
tRNA
, or ribosomal subunits, but did inhibit export of 5S rRNA and spliceosomal U snRNAs. BSA-R was itself exported from the nucleus in an active, saturable manner. Thus, the Rev activation domain constitutes a nuclear export signal that redirects RRE-containing viral RNAs to a non-mRNA export pathway.
...
PMID:The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. 754 68
The initiation of human immunodeficiency virus type 1 (HIV-1) reverse transcription occurs at a site in the viral RNA genome which is designated the primer-binding site (PBS). The
HIV
-1 PBS is an 18-nucleotide sequence that is complementary to the 3'-terminal 18 nucleotides of
tRNA
(3Lys), which is used as the primer for reverse transcription. All
HIV
-1 isolates sequenced to date contain a PBS complementary to
tRNA
(3Lys), suggesting that other cellular tRNAs might not function as primers for reverse transcription. To investigate this possibility, we have substituted the
HIV
-1 PBS with sequences predicted to be complementary to the 3'-terminal nucleotides of
tRNA
(1,2Lys),
tRNA
(Ile), and
tRNA
(His), which previous studies have identified to be packaged into
HIV
-1 virions along with
tRNA
(3Lys). We demonstrate that infectious viruses which utilized
tRNA
(1,2Lys),
tRNA
(Ile), and
tRNA
(His) in reverse transcription can be recovered. However, the appearances of viruses with PBSs complementary to these alternate tRNAs were delayed compared with the wild type. After extended in vitro culture, viruses containing the PBSs complementary to these different tRNAs reverted back to the wild-type PBS complementary to tRNA3(Lys). Furthermore, only the first 9 nucleotides of the 18 nucleotide PBSs were sufficient for
HIV
-1 to utilize the alternate
tRNA
primers in reverse transcription, demonstrating that
HIV
-1 does not require the complete 18-nucleotide PBS to utilize these
tRNA
primers for reverse transcription. These results suggest that factors other than complementarity between the PBS and the primer
tRNA
contribute to the selectivity of tRNA3(Lys) to initiate
HIV
-1 reverse transcription.
...
PMID:Human immunodeficiency virus type 1 can use different tRNAs as primers for reverse transcription but selectively maintains a primer binding site complementary to tRNA(3Lys). 754 40
Reverse transcription of the human immunodeficiency virus type 1 (HIV-1) RNA genome is primed by the cellular
tRNA
Lys3 molecule. Packaging of this
tRNA
primer during virion assembly is thought to be mediated by specific interactions with the reverse transcriptase (RT) protein. Portions of the
tRNA
molecule that are required for interaction with the RT protein remain poorly defined. We have used an RNA gel mobility shift assay to measure the in vitro binding of purified RT to mutant forms of
tRNA
Lys3. The anticodon loop could be mutated without eliminating RT recognition. However, mutations in the T psi C stem were found to partially interfere with RT binding, and D arm mutants were completely inactive in RT binding. Interestingly, binding of the RT protein to
tRNA
Lys3 facilitates the subsequent annealing of template strand to the 3'-terminus of the
tRNA
molecule. Consistent with this finding, we demonstrate that mutant
HIV
-1 virions lacking the RT protein do contain a viral RNA genome without an associated
tRNA
Lys3 primer. We also found that a preformed primer
tRNA
-template complex is efficiently recognized by RT protein in vitro. Extension of the template molecule over the T psi C loop did result in complete inhibition of RT binding, suggesting the presence of additional recognition elements in the T psi C loop. These results, combined with a comparative sequence analysis of
tRNA
species present in
HIV
-1 virions and RNA motifs selected in vitro for high affinity RT binding, suggest that RT recognizes the central domain of the
tRNA
tertiary structure, which is formed by interaction of the D and T psi C loops.
...
PMID:Structural requirements for the binding of tRNA Lys3 to reverse transcriptase of the human immunodeficiency virus type 1. 755 65
TAR decoys are short RNA oligonucleotides, corresponding to the
HIV
TAR sequence, which inhibit
HIV
expression and replication by blocking the binding of the
HIV
regulatory protein Tat to the authentic TAR region. In previous studies, TAR decoys expressed from a
tRNA
polIII promoter were moderately effective at inhibiting
HIV
in isolated human T cell lines and less effective at inhibiting
HIV
in peripheral blood CD4+ T cells. In this study, a series of modifications was introduced into the
tRNA
expression cassette in order to improve their effectiveness. These modifications included the addition of sequences which are predicted to have stem-loop secondary structures and addition of a wild-type
tRNA
processing site. TAR decoy RNA expressed in CEM cells from modified
tRNA
-based expression cassettes yielded five- to 20-fold more TAR transcripts than unmodified
tRNA
-based expression cassettes.
HIV
replication, as measured by a flow cytometric method to quantify intracellular viral p24 expression, was significantly reduced in polyclonal populations of CEM cells expressing a modified
tRNA
-TAR transcript that contains a wild-type
tRNA
processing site and stem-loops 5' and 3' to the TAR sequence. Similar modifications to the
tRNA
expression cassette also increased the intracellular concentration of a random test oligonucleotide, indicating that this improved expression system may also be useful for antisense and ribozyme based gene inhibition strategies.
...
PMID:Inhibition of HIV-1 in CEM cells by a potent TAR decoy. 758 12
HIV
-1 RT is able to catalyze DNA synthesis starting from mononucleotides used both as minimal primers and as nucleotide substrates (de novo synthesis) in the presence of a complementary template. The rate of this process is rather slow when compared to the polymerization primed by an oligonucleotide. The addition of
tRNA
(Lys,3) to this system increased the de novo synthesis rate by 2-fold. Addition of low concentrations of agents able to modify protein conformation, such as urea, dimethylsulfoxide and Triton X-100, can activate the de novo synthesis by a factor 2 to 5. A dramatic synergy is observed in the presence of the three compounds since the stimulating effect of
tRNA
increases 10-15 times. These results suggest that compounds activating RT are able to induce a conformational change of the enzyme which results in a higher specific activity. Primer
tRNA
seems to play an important role in
HIV
-1 RT modification(s) leading to a polymerase having a higher affinity for the primer or the dTTP, but not for the template. The specificity of RT for the template is not influenced by changes in the kinetics or in the thermodynamic parameters of the polymerization reaction.
...
PMID:DNA synthesis primed by mononucleotides (de novo synthesis) catalyzed by HIV-1 reverse transcriptase: tRNA(Lys,3) activation. 758 77
The nucleocapsid protein NCp15 of human immunodeficiency virus type 1 (HIV-1) is a small basic protein with two zinc fingers. It is required for virion morphogenesis and synthesis of proviral DNA. As the first step in our study of the structural domains involved in the various functions of this protein, 18 monoclonal antibodies (MAbs) were isolated. The epitopes of NCp7 recognized by the MAbs were mapped using synthetic peptides representing overlapping sequences and truncated forms of NCp7. These anti-NCp7 MAbs were investigated by ELISA and real-time biospecific interaction analysis (BIAcore). Five classes of anti-NCp7 MAbs were characterized. Three classes (14 MAbs) were directed against continuous epitopes, one in the N-terminal part, another next to the second zinc finger and the third in the C-terminal part of the protein. Two other classes comprised four MAbs reacting only with the entire NCp7 and not with any of the small overlapping peptides used, suggesting that these MAbs were directed against conformational epitopes. The anti-NCp7 MAbs directed against linear epitopes were able to react efficiently with both NCp7 and NCp15, the NCp7 precursor, whereas the anti-NCp7 MAbs directed against conformational epitopes did not react with NCp15. Interestingly, most of the anti-NCp7 MAbs directed against conformational epitopes were capable of inhibiting the tight interaction between NCp7 and the
HIV
-1 replication primer
tRNA
(Lys,3). In contrast, most of the MAbs directed against linear epitopes did not inhibit this interaction.
...
PMID:Conformational changes between human immunodeficiency virus type 1 nucleocapsid protein NCp7 and its precursor NCp15 as detected by anti-NCp7 monoclonal antibodies. 759 49
RNA polymerase III (pol III) transcripts are abundant in all cells. Therefore, pol III promoters may be ideal for expressing high levels of exogenous RNAs, such as antisense RNAs, decoy RNAs and ribozymes, in many different cell types. We have improved accumulation of recombinant RNAs expressed from a human meti
tRNA
-derived pol III promoter > 100-fold by modifying the 3' terminus of the transcripts to hybridize to the 5' terminus. This terminal duplex includes the 8 nt leader sequence present in the primary wild-type meti
tRNA
transcript that is normally removed during processing to the mature
tRNA
. Expression of an anti-
HIV
ribozyme was analyzed in cells stably transduced with retroviral vectors encoding pol III transcription units containing this modification. High accumulation of recombinant pol III ribozyme transcripts was observed in all cell lines tested. Due to the enhanced transcript accumulation, ribozyme cleavage activity was readily detectable in total RNA extracted from stably transduced human T cell lines. One pol III transcription unit, termed 'TRZ', was optimized further for ribozyme cleavage activity. The improved pol III transcription units reported here may be useful for expressing a variety of functional and therapeutic RNAs.
...
PMID:Improved accumulation and activity of ribozymes expressed from a tRNA-based RNA polymerase III promoter. 761 54
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>